Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$19.84 USD
-0.15 (-0.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $19.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.84 USD
-0.15 (-0.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $19.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Zacks News
Fulgent Genetics, Inc. (FLGT) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.12% and 6.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Computer Programs and Systems (CPSI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Analysts Estimate Fullgent Genetics (FLGT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Fullgent Genetics (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Strategic investments and expanding operations in China are likely to have contributed to Fulgent Genetics' (FLGT) first-quarter performance.
Fullgent Genetics (FLGT) Stock Moves -1.28%: What You Should Know
by Zacks Equity Research
Fullgent Genetics (FLGT) closed at $56.44 in the latest trading session, marking a -1.28% move from the prior day.
Fullgent Genetics (FLGT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Fullgent Genetics (FLGT) closed at $61.50 in the latest trading session, marking a +0.87% move from the prior day.
Is Fulgent Genetics (FLGT) a Suitable Value Investor Stock?
by Zacks Equity Research
Let's see if Fulgent Genetics (FLGT) stock is a good choice for value-oriented investors right now from multiple angles.
Fullgent Genetics (FLGT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics (FLGT) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.
Are These Medical Stocks a Great Value Stocks Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fullgent Genetics (FLGT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Fullgent Genetics (FLGT) closed at $65.84, marking a -0.98% move from the previous day.
4 Best Stocks With High Net Income Ratio to Grab Today
by Nitish Marwah
OPBK, BBW, EVRI, and FLGT qualified the screen for stocks with a high net income ratio.
Fullgent Genetics (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Fullgent Genetics (FLGT) closed the most recent trading day at $71.50, moving +0.14% from the previous trading session.
Fullgent Genetics (FLGT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Fullgent Genetics (FLGT) closed at $63.87, marking a +1.96% move from the previous day.
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
FLGT, AAWW, BBW, and QDEL passed the screen for the stocks with a high net income ratio.
New Strong Buy Stocks for January 26th
by Zacks Equity Research
FLGT, LPX, STC, GFED, and FBNC have been added to the Zacks Rank #1 (Strong Buy) List on January 26th.
Fullgent Genetics (FLGT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Fullgent Genetics (FLGT) closed at $60.72 in the latest trading session, marking a +0.03% move from the prior day.
Fullgent Genetics (FLGT) Stock Moves -0.62%: What You Should Know
by Zacks Equity Research
Fullgent Genetics (FLGT) closed at $81.34 in the latest trading session, marking a -0.62% move from the prior day.
Fullgent Genetics (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Fullgent Genetics (FLGT) closed at $81.25, marking a +1.4% move from the previous day.
4 Profitable Stocks to Boost Returns Using Net Income Ratio
by Nitish Marwah
FLGT, LGO, CTRN, and TGH have been selected as the top picks with a high net income ratio.
Buy These 3 Stocks With Momentum Anomaly for Higher Returns
by Sandip Chakraborty
Avis Budget Group (CAR), Signet Jewelers (SIG) and Fulgent Genetics (FLGT) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
New Strong Buy Stocks for December 28th
by Zacks Equity Research
AAWW, BERY, CAL, FLGT, and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on December 28th.
Best Momentum Stocks to Buy for December 28th
by Zacks Equity Research
MUSA, JOAN, FLGT, and AHH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 28, 2021.
Has Bio-Rad Laboratories (BIO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Bio-Rad Laboratories (BIO) and Fullgent Genetics (FLGT) have performed compared to their sector so far this year.
Best Momentum Stocks to Buy for December 21st
by Zacks Equity Research
AMTB, BBW, FLGT, and BLDR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 21, 2021.